Lexeo Therapeutics (LXEO) Q2 2026 Earnings

May 11Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.99
-0.74
-0.5
-0.25

Details

Expected EPS
-0.309139
Actual EPS
-0.25
Surprise EPS
0.06
Surprise Percent
+19.13%

Description

⁨Lexeo Therapeutics⁩ (⁦LXEO⁩) has reported earnings of ⁦-0.25⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts